| Protocols | ||
|---|---|---|
| 1 protocol(s) meet the specified criteria | ||
| Drug: INTERFERON ALFA-2B | ||
| Protocol No. | Title | Status |
| ECOG1609-CIRB | A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Vs High Dose Interferon alpha2b for Resected High-Risk Melanoma | Open (affiliates only) |